CPT 0319U: PreTransplant Risk Assessment by NGS Transcriptome
CPT code 0319U is a Proprietary Laboratory Analyses (PLA) test for PreTransplant Risk Assessment (PTRA) from Verici Dx Inc., using next-generation sequencing (NGS) of targeted transcriptome (mRNA) regions from a patient blood specimen to evaluate immune-response gene expression and generate an algorithmic risk score for early acute kidney transplant rejection; service type: laboratory molecular diagnostic assay using NGS; typical site of service: clinical laboratory or hospital lab processing pre-transplant blood specimens.
For related coverage guidance, see recent payer policy updates: RTM Testing of Homocysteine Metabolism-Related Conditions, Multimarker Serum Testing Related to Ovarian Cancer, Genomic Profiling for Selecting Targeted Cancer Therapies.
Customize your policy alerts
Sign up for cpt 0319U policy alerts
Get alerted when payer policies referencing 0319U are released or updated.
Monitor payer policy activity